Toremifene

In the US, Toremifene (toremifene systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:

• Toremifene


• Toremifene Citrate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02BA02

CAS registry number (Chemical Abstracts Service)

0089778-26-7

Chemical Formula

C26-H28-Cl-N-O

Molecular Weight

405

Therapeutic Categories

Antineoplastic agent

Antiestrogen

Chemical Name

2-[p-[(Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethylamine

Foreign Names

• Toremifenum (Latin)
• Toremifen (German)
• Torémifène (French)
• Toremifeno (Spanish)

Generic Names

• Toremifene (OS: BAN)
• Torémifène (OS: DCF)
• FC 1157 (IS: FarmosGroupLt)
• Toremifene Citrate (OS: USAN)
• FC 1157a (IS: FarmosGroupLt)

Brand Names

• Fareston
  Abdi Ibrahim, Turkey; Orion, United Arab Emirates; Orion, Bahrain; Orion, Czech Republic; Orion, Egypt; Orion, Ireland; Orion, Iraq; Orion, Iran; Orion, Jordan; Orion, Kuwait; Orion, Lebanon; Orion, Oman; Orion, Qatar; Orion, Saudi Arabia; Orion, Slovenia; Orion, Syria; Orion, Taiwan; Orion, Yemen; Baxter, Belgium; Baxter Oncology, Germany; GTx, United States; HRA, France; Nippon Kayaku, Japan; Orion, Austria; Orion, Switzerland; Orion, Finland; Orion, Finland; Orion, United Kingdom; Orion, Georgia; Orion, Hungary; Orion, Luxembourg; Orion, Russian Federation; Orion, Sweden; Schering-Plough, Australia; Schering-Plough, Bahrain; Schering-Plough, Spain; Schering-Plough, Italy; Schering-Plough, New Zealand; Schering-Plough, Portugal; Schering-Plough, Thailand; Schering-Plough, South Africa



• Toremifene
  Medisa Shinyaku, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.